1 |
Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174.
DOI
|
2 |
Janssen MF, Bonsel GJ, Luo N. Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries. Pharmacoeconomics 2018;36(6):675-697.
DOI
|
3 |
Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics 2016;34(7):645-649.
DOI
|
4 |
Health Insurance Review and Assessment Service. Guidelines for economic evaluation of pharmaceuticals. 2nd ed. Wonju: Health Insurance Review and Assessment Service; 2011, p. 10 (Korean).
|
5 |
Jo MW. Development of the measurement tool for health related quality of life in the Korea National Health and Nutrition Examination Survey. Cheongju: Korea Centers for Disease Control and Prevention; 2014, p. 97 (Korean).
|
6 |
Kim SK, Kim SH, Jo MW, Lee SI. Estimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke. Health Qual Life Outcomes 2015;13:32.
DOI
|
7 |
Viera AJ, Garrett JM. Understanding interobserver agreement: the kappa statistic. Fam Med 2005;37(5):360-363.
|
8 |
Kim TH, Jo MW, Lee SI, Kim SH, Chung SM. Psychometric properties of the EQ-5D-5L in the general population of South Korea. Qual Life Res 2013;22(8):2245-2253.
DOI
|
9 |
Ock M, Jo MW, Lee SI. Measuring health related quality of life using EQ-5D in South Korea. J Health Tech Assess 2013;1(1):103-111 (Korean).
|
10 |
Kim SH, Jo MW, Lee SI. Psychometric properties of the Korean short form-36 health survey version 2 for assessing the general population. Asian Nurs Res (Korean Soc Nurs Sci) 2013;7(2):61-66.
DOI
|
11 |
Maruish ME. User's manual for the SF-36v2 health survey. 3rd ed. Lincoln: Quality Metric Incorporated; 2011, p. 198.
|
12 |
Lee HJ, Jo MW, Choi SH, Kim YJ, Oh KW. Development and psychometric evaluation of measurement instrument for Korean health-related quality of life. Public Health Wkly Rep 2016;9(24):447-454 (Korean).
|
13 |
Hu J, Gruber KJ, Hsueh KH. Psychometric properties of the Chinese version of the SF-36 in older adults with diabetes in Beijing, China. Diabetes Res Clin Pract 2010;88(3):273-281.
DOI
|
14 |
Jo MW. Valuation of Korean health-related quality of life instrument with 8 items (HINT-8). Cheongju: Korean Centers for Disease Control and Prevention; 2017, p. 28 (Korean).
|
15 |
Brazier JE, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004;42(9):851-859.
DOI
|
16 |
Streiner DL, Norman GR, Cairney J. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2014, p. 177.
|
17 |
Forssas E, Arffman M, Manderbacka K, Keskimaki I, Ruuth I, Sund R. Multiple complications among people with diabetes from Finland: an 18-year follow-up in 1994-2011. BMJ Open Diabetes Res Care 2016;4(1):e000254.
DOI
|
18 |
Fayers PM, Hays R, Hays RD. Assessing quality of life in clinical trials: methods and practice. 2nd ed. Oxford: Oxford University Press; 2005, p. 421.
|
19 |
Mulhern B, Meadows K. The construct validity and responsiveness of the EQ-5D, SF-6D and diabetes health profile-18 in type 2 diabetes. Health Qual Life Outcomes 2014;12:42.
DOI
|
20 |
Koh D, Abdullah AM, Wang P, Lin N, Luo N. Validation of Brunei's Malay EQ-5D questionnaire in patients with type 2 diabetes. PLoS One 2016;11(11):e0165555.
DOI
|
21 |
Kim KJ, Kwon TY, Yu S, Seo JA, Kim NH, Choi KM, et al. Ten-year mortality trends for adults with and without diabetes mellitus in South Korea, 2003 to 2013. Diabetes Metab J 2018;42(5):394-401.
DOI
|
22 |
Janssen MF, Birnie E, Haagsma JA, Bonsel GJ. Comparing the standard EQ-5D three-level system with a five-level version. Value Health 2008;11(2):275-284.
DOI
|
23 |
Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia 2019;62(1):3-16.
DOI
|
24 |
Won JC, Lee JH, Kim JH, Kang ES, Won KC, Kim DJ, et al. Diabetes fact sheet in korea, 2016: an appraisal of current status. Diabetes Metab J 2018;42(5):415-424.
DOI
|
25 |
Kim SH, Jo MW, Lee JW, Lee HJ, Kim JK. Validity and reliability of EQ-5D-3L for breast cancer patients in Korea. Health Qual Life Outcomes 2015;13:203.
DOI
|
26 |
Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract 2018;138:271-281.
DOI
|
27 |
Lee JW, Kang HT, Lim HJ, Park B. Trends in diabetes prevalence among Korean adults based on Korean National Health and Nutrition Examination Surveys III-VI. Diabetes Res Clin Pract 2018;138:57-65.
DOI
|
28 |
Megari K. Quality of life in chronic disease patients. Health Psychol Res 2013;1(3):e27.
DOI
|
29 |
El Achhab Y, Nejjari C, Chikri M, Lyoussi B. Disease-specific health-related quality of life instruments among adults diabetic: a systematic review. Diabetes Res Clin Pract 2008;80(2):171-184.
DOI
|
30 |
Lee EH, Kim CJ, Cho SY, Chae HJ, Lee S, Kim EJ. Monitoring the use of health-related quality of life measurements in Korean studies of patients with diabetes. J Korean Acad Nurs 2011;41(4):558-567(Korean).
DOI
|
31 |
Kiadaliri AA, Eliasson B, Gerdtham UG. Does the choice of EQ-5D tariff matter? A comparison of the Swedish EQ-5D-3L index score with UK, US, Germany and Denmark among type 2 diabetes patients. Health Qual Life Outcomes 2015;13:145.
DOI
|
32 |
Kim SH, Ahn J, Ock M, Shin S, Park J, Luo N, et al. The EQ-5D-5L valuation study in Korea. Qual Life Res 2016;25(7):1845-1852.
DOI
|
33 |
Kim SH, Hwang JS, Kim TW, Hong YS, Jo MW. Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer 2012;20(12):3155-3160.
DOI
|
34 |
Lee WJ, Song KH, Noh JH, Choi YJ, Jo MW. Health-related quality of life using the EuroQol 5D questionnaire in Korean patients with type 2 diabetes. J Korean Med Sci 2012;27(3):255-260.
DOI
|
35 |
Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21(2):271-292.
DOI
|
36 |
Kim SH, Kim HJ, Lee SI, Jo MW. Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea. Qual Life Res 2012;21(6):1065-1073.
DOI
|
37 |
Lee YK, Nam HS, Chuang LH, Kim KY, Yang HK, Kwon IS, et al. South Korean time trade-off values for EQ-5D health states: modeling with observed values for 101 health states. Value Health 2009;12(8):1187-1193.
DOI
|
38 |
van Reenen M, Janssen B. EQ-5D-5L user guide: basic information on how to use the EQ-5D-5L instrument. Rotterdam: EuroQol Research Foundation; 2015, p. 9.
|
39 |
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15(2):155-163.
DOI
|
40 |
Janssen MF, Pickard AS, Golicki D, Gudex C, Niewada M, Scalone L, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study. Qual Life Res 2013;22(7):1717-1727.
DOI
|